Artwork

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap

37:17
 
分享
 

Manage episode 347457799 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:

  • COVID-19 vaccines, including omicron BA.1 bivalent booster
  • Risk factors for breakthrough COVID-19 infections
  • COVID-19 diagnostics, including digital droplet PCR
  • COVID-19 therapeutics, including:
    • Nirmatrelvir plus ritonavir
    • Tixagevimab plus cilgavimab
    • Baricitinib
    • Tocilizumab
    • Inhaled interferon β-1a
  • COVID-19 therapeutics and outcomes in patients with immunocompromise
  • Long COVID

Presenters:
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Follow along with the downloadable slideset at:
http://bit.ly/3gkJI67

Link to full program:
http://bit.ly/3TSVthM

  continue reading

378集单集

Artwork
icon分享
 
Manage episode 347457799 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:

  • COVID-19 vaccines, including omicron BA.1 bivalent booster
  • Risk factors for breakthrough COVID-19 infections
  • COVID-19 diagnostics, including digital droplet PCR
  • COVID-19 therapeutics, including:
    • Nirmatrelvir plus ritonavir
    • Tixagevimab plus cilgavimab
    • Baricitinib
    • Tocilizumab
    • Inhaled interferon β-1a
  • COVID-19 therapeutics and outcomes in patients with immunocompromise
  • Long COVID

Presenters:
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Follow along with the downloadable slideset at:
http://bit.ly/3gkJI67

Link to full program:
http://bit.ly/3TSVthM

  continue reading

378集单集

Усі епізоди

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南